These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38435431)

  • 1. Clinical relevance of circulating tumor DNA in ovarian cancer: current issues and future opportunities.
    Trevisi E; Sessa C; Colombo I
    Explor Target Antitumor Ther; 2024; 5(3):627-640. PubMed ID: 38966171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway.
    Bae S; Bae S; Kim HS; Lim YJ; Kim G; Park IC; So KA; Kim TJ; Lee JH
    Cancer Manag Res; 2024; 16():507-525. PubMed ID: 38827785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special Issue "Ovarian Cancer: Advances on Pathophysiology and Therapies".
    Tossetta G; Inversetti A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of
    Chen X; Li Z; Feng Y; Yang Z; Zhao B
    Int J Gen Med; 2024; 17():2113-2128. PubMed ID: 38766598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian tumor markers of presumed benign ovarian tumors].
    Lahlou N; Brun JL
    J Gynecol Obstet Biol Reprod (Paris); 2013 Dec; 42(8):752-9. PubMed ID: 24210243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
    Ghose A; McCann L; Makker S; Mukherjee U; Gullapalli SVN; Erekkath J; Shih S; Mahajan I; Sanchez E; Uccello M; Moschetta M; Adeleke S; Boussios S
    Ther Adv Med Oncol; 2024; 16():17588359241233225. PubMed ID: 38435431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women.
    Davenport C; Rai N; Sharma P; Deeks JJ; Berhane S; Mallett S; Saha P; Champaneria R; Bayliss SE; Snell KI; Sundar S
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD011964. PubMed ID: 35879201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass.
    Karlsen MA; Sandhu N; Høgdall C; Christensen IJ; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Lydolph M; Laursen IA; Høgdall EV
    Gynecol Oncol; 2012 Nov; 127(2):379-83. PubMed ID: 22835718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer: A Meta-analysis.
    Dayyani F; Uhlig S; Colson B; Simon K; Rolny V; Morgenstern D; Schlumbrecht M
    Int J Gynecol Cancer; 2016 Nov; 26(9):1586-1593. PubMed ID: 27540691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic accuracy of two human epididymis protein 4 (HE4) testing systems in combination with CA125 in the differential diagnosis of ovarian masses.
    Lenhard M; Stieber P; Hertlein L; Kirschenhofer A; Fürst S; Mayr D; Nagel D; Hofmann K; Krocker K; Burges A
    Clin Chem Lab Med; 2011 Sep; 49(12):2081-8. PubMed ID: 21923475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Value of Serum HE4, CA125, CA72-4, and ROMA Index for Diagnosis of Ovarian Cancer and Prediction of Postoperative Recurrence.
    Wang Q; Wu Y; Zhang H; Yang K; Tong Y; Chen L; Zhou Q; Guan S
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer.
    Boussios S; Devo P; Goodall ICA; Sirlantzis K; Ghose A; Shinde SD; Papadopoulos V; Sanchez E; Rassy E; Ovsepian SV
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer.
    Parent P; Marcq G; Adeleke S; Turpin A; Boussios S; Rassy E; Penel N
    Ther Adv Med Oncol; 2023; 15():17588359231192402. PubMed ID: 37692364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
    Hanžek A; Siatka C; Duc AE
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.